Taken together, abrogating MCP expression results in a near-complete blockade of tumor monocyte recruitment and a compensatory influx of neutrophils, which is associated with increased expression of Cxcl, Cxcl2 and Gm-csf. The gene discussed is CSF2; the disease is neoplasm.